Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$807,810
-$1,910,645 QoQ
Shares Held
86,582
-68.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#151
of 639 holders
Holding Since
Sep 2022
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. HLN ranks #23 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
4,217,767 | $146,229,981 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
4,432,350 | $109,080,132 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
773,978 | $85,865,119 | |
| 4 | ALKS |
Alkermes plc.
|
969,954 | $50,825,589 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
270,754 | $45,632,878 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
2,025,356 | $29,347,408 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
1,066,322 | $21,518,377 | |
| 8 | ZTS |
Zoetis Inc.
|
257,470 | $18,501,794 |
All Filings in HLN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $807,810 | 86,582 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $2,718,455 | 271,574 | Shares | Other | 2026-05-15 | |
| 2025-06-30 | $631,988 | 60,944 | Shares | Other | 2025-08-13 | |
| 2022-09-30 | $352,002 | 57,800 | Shares | Other | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||